
Avient Corp (AVNT) Stock Forecast & Price Target
Avient Corp (AVNT) Analyst Ratings
Bulls say
Avient Corp has demonstrated strong performance, with organic sales increasing by 5% and healthcare sales witnessing double-digit growth, specifically a 14% year-over-year rise in the first half of 2025. The company benefits from a diversified product portfolio across multiple industries, and four out of nine key end markets contributing to 40% of its sales are experiencing growth this year. Despite anticipated challenges in the consumer end market for the second half of 2025, the overall outlook remains positive, bolstered by resilient sales in healthcare and other segments.
Bears say
Avient Corp has experienced fluctuating organic sales, with a decline of approximately 2% in 1Q24, followed by modest growth of 5% in 2Q and 4Q, and a significant 9% increase in 3Q, signaling potential instability in revenue performance. The demand for chemicals has been weakening since mid-2025, raising concerns over potential volume declines in the second half of 2025, which could negatively impact future financial results. Despite a recent decrease in the dollar's value, which may offer some benefits, the underlying trends in demand suggest increasing risks for Avient's growth and financial health.
This aggregate rating is based on analysts' research of Avient Corp and is not a guaranteed prediction by Public.com or investment advice.
Avient Corp (AVNT) Analyst Forecast & Price Prediction
Start investing in Avient Corp (AVNT)
Order type
Buy in
Order amount
Est. shares
0 shares